Metraipolis › archive › dc_8b68a4ff416d
Overcoming Barriers to Clinical Translation: MG1 Maraba Virus as an Emerging Platform for Oncolytic Immunotherapy — Europe PMC PMID:42357627
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42357627
- DOI
- 10.3390/v18060617
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T03:27:49.881Z
- SHA-256 of the archived text
5fdac21b4c0a732e124033ad27f199d1f83da2df555240b27061dc89497d5f54- Stable URL of this page
https://metraipolis.com/documento/dc_8b68a4ff416d
How to cite
Overcoming Barriers to Clinical Translation: MG1 Maraba Virus as an Emerging Platform for Oncolytic Immunotherapy — Europe PMC PMID:42357627 — Europe PMC (en), https://europepmc.org/article/MED/42357627 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8b68a4ff416d (Metraipolis archive dc_8b68a4ff416d, sha256 5fdac21b4c0a732e124033ad27f199d1f83da2df555240b27061dc89497d5f54)
BibTeX
@misc{dc8b68a4ff416d,
title = {Overcoming Barriers to Clinical Translation: MG1 Maraba Virus as an Emerging Platform for Oncolytic Immunotherapy — Europe PMC PMID:42357627},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42357627},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8b68a4ff416d; sha256 5fdac21b4c0a732e124033ad27f199d1f83da2df555240b27061dc89497d5f54},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42357627. Agents can read the archived copy with the MCP tool read_document.